US2009305349A1PendingUtilityA1
Expression of soluble factor viii proteins in bacteria
Est. expiryOct 31, 2025(expired)· nominal 20-yr term from priority
C07K 14/755
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides enhanced methods of producing soluble Factor VIII proteins in microorganisms that have an oxidizing environment.
Claims
exact text as granted — not AI-modified1 . A method of producing a soluble Factor VIII protein in a microorganism, wherein the microorganism has an oxidizing environment,
the method comprising the steps of a) expressing in the microorganism a nucleic acid that encodes the Factor VIII protein; and b) growing the microorganism under conditions that allow production of the soluble Factor VIII protein.
2 . The method of claim 1 , wherein the microorganism is an E. coli.
3 . The method of claim 2 , wherein the E. coli has a mutation in a trxB gene and a gor gene.
4 . The method of claim 2 , wherein the nucleic acid is expressed under the control of an inducible promoter.
5 . The method of claim 4 , wherein expression of the nucleic acid is induced at a temperature lower than an optimal growth temperature.
6 . The method of claim 1 , wherein the microorganism has a mutation in an endogenous reductase nucleic acid.
7 . The method of claim 1 , wherein the microorganism is grown at a temperature lower than an optimal growth temperature.
8 . The method of claim 1 , further comprising the step of isolating the soluble factor VIII protein.
9 . The method of claim 1 , wherein the soluble Factor VIII protein is produced on a commercial scale.
10 . The method of claim 1 , wherein the Factor VIII protein comprises a purification tag.
11 . The method of claim 10 , wherein the purification tag is removed from the Factor VIII protein.
12 . The method of claim 1 , wherein the microorganism comprises a heterologous protein disulfide isomerase (PDI).
13 . The method of claim 1 , wherein the microorganism comprises a heterologous chaperone protein.
14 . The method of claim 1 , wherein the Factor VIII protein exhibits enzymatic or biological activity.
15 . The method of claim 1 , wherein all or a portion of a B-domain is deleted from the Factor VIII protein.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.